Literature DB >> 12631633

Drug-eluting stents: potential applications for peripheral arterial occlusive disease.

Stephan H Duda1, Tudor C Poerner, Benjamin Wiesinger, John H Rundback, Gunnar Tepe, Jakub Wiskirchen, Karl K Haase.   

Abstract

Many different approaches have been evaluated to prevent restenosis in stents after vascular implantation. Currently, drug-eluting stents are extremely promising in suppressing neointimal hyperplasia. Various animal studies and randomized trials in humans have shown excellent results in terms of safety and efficacy during intermediate-term follow-up. This article will give an overview of experimental and clinical data of the different agents in published and ongoing trials.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12631633     DOI： 10.1097/01.rvi.0000058423.01661.57

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN： 1051-0443            Impact factor:   3.464


  14 in total

1.  Regulation of vascular smooth muscle cell growth: targeting the final common pathway.

Authors:  Angela M Taylor; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-01       Impact factor: 8.311

Review 2.  Superficial femoral artery: current treatment options.

Authors:  Gunnar Tepe; Jörg Schmehl; Stephan Heller; Benjamin Wiesinger; Claus D Claussen; Stephan H Duda
Journal:  Eur Radiol       Date:  2006-02-18       Impact factor: 5.315

Review 3.  Peripheral arterial disease: clinical assessment and indications for revascularization in the patient with diabetes.

Authors:  Bart E Muhs; Paul Gagne; Peter Sheehan
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

4.  Fatigue and in vivo validation of a peritoneum-lined self-expanding nitinol stent-graft.

Authors:  Jennifer M Bastijanic; Jordan Etscheidt; Mallika Sattiraju; Craig Bonsignore; George Kopchok; Rodney White; Timur P Sarac
Journal:  J Endovasc Ther       Date:  2014-10       Impact factor: 3.487

5.  Quantitative trait locus analysis of neointimal formation in an intercross between C57BL/6 and C3H/HeJ apolipoprotein E-deficient mice.

Authors:  Zuobiao Yuan; Hong Pei; Drew J Roberts; Zhimin Zhang; Jessica S Rowlan; Alan H Matsumoto; Weibin Shi
Journal:  Circ Cardiovasc Genet       Date:  2009-06

Review 6.  Drug-eluting stents in renal artery stenosis.

Authors:  M Zähringer; P M T Pattynama; A Talen; M Sapoval
Journal:  Eur Radiol       Date:  2007-10-11       Impact factor: 5.315

7.  Candesartan treatment for peripheral occlusive arterial disease after stent angioplasty : a randomised, placebo-controlled trial.

Authors:  C Schindler; J Schweizer; A Müller; R Koch; G Hellner; W Fuchs; W Kirch
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

8.  Self-expanding nitinol stents for treatment of infragenicular arteries following unsuccessful balloon angioplasty.

Authors:  Gunnar Tepe; Thomas Zeller; Stephan Heller; Jakub Wiskirchen; Arne Fischmann; Stephan Coerper; Bernd Balletshofer; Stefan Beckert; Claus D Claussen
Journal:  Eur Radiol       Date:  2006-12-21       Impact factor: 7.034

9.  Efficacy of a dexamethasone-eluting nitinol stent on the inhibition of pseudo-intimal hyperplasia in a transjugular intrahepatic portosystemic shunt: an experimental study in a swine model.

Authors:  Tae Seok Seo; Joo Hyeong Oh; Young Koo Park; Ho Young Song; Sang Joon Park; Sun Hong Yuk
Journal:  Korean J Radiol       Date:  2005 Oct-Dec       Impact factor: 3.500

10.  Nanostructured ultra-thin patches for ultrasound-modulated delivery of anti-restenotic drug.

Authors:  Lorenzo Vannozzi; Leonardo Ricotti; Carlo Filippeschi; Stefania Sartini; Vito Coviello; Vincenzo Piazza; Pasqualantonio Pingue; Concettina La Motta; Paolo Dario; Arianna Menciassi
Journal:  Int J Nanomedicine       Date:  2015-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.